These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 3877566)
1. Inhibition of endometrial carcinoma cell cultures by a synthetic androgen. Centola GM Cancer Res; 1985 Dec; 45(12 Pt 1):6264-7. PubMed ID: 3877566 [TBL] [Abstract][Full Text] [Related]
2. Regulation of renal N-nitrosodimethylamine demethylase activity by androgens, progestin, glucocorticoid, and estrogen in BALB/c mice. Ahir S; Mohla S Cancer Res; 1989 Jul; 49(14):3737-41. PubMed ID: 2786744 [TBL] [Abstract][Full Text] [Related]
3. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276 [TBL] [Abstract][Full Text] [Related]
4. Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithelial cells. Syed V; Ulinski G; Mok SC; Yiu GK; Ho SM Cancer Res; 2001 Sep; 61(18):6768-76. PubMed ID: 11559549 [TBL] [Abstract][Full Text] [Related]
5. Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line. Hofbauer LC; Hicok KC; Khosla S J Cell Biochem; 1998 Oct; 71(1):96-108. PubMed ID: 9736458 [TBL] [Abstract][Full Text] [Related]
6. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Gregory CW; Johnson RT; Mohler JL; French FS; Wilson EM Cancer Res; 2001 Apr; 61(7):2892-8. PubMed ID: 11306464 [TBL] [Abstract][Full Text] [Related]
7. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
8. Stimulative effect of physiological doses of androgen or pharmacological doses of estrogen on growth of Shionogi carcinoma 115 in mice. Noguchi S; Nishizawa Y; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K Cancer Res; 1985 Nov; 45(11 Pt 2):5746-50. PubMed ID: 4053046 [TBL] [Abstract][Full Text] [Related]
9. Effects of 17beta-estradiol and progesterone on growth and morphology of human endometrial carcinoma cells in vitro. Ishiwata I; Nozawa S; Okumura H Cancer Res; 1977 Dec; 37(12):4246-9. PubMed ID: 562709 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115. Noguchi S; Takatsuka D; Kitamura Y; Terada N; Uchida N; Yamaguchi K; Sato B; Matsumoto K Cancer Res; 1985 Oct; 45(10):4785-90. PubMed ID: 4027967 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Hamilton TC; Young RC; McKoy WM; Grotzinger KR; Green JA; Chu EW; Whang-Peng J; Rogan AM; Green WR; Ozols RF Cancer Res; 1983 Nov; 43(11):5379-89. PubMed ID: 6604576 [TBL] [Abstract][Full Text] [Related]
12. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines. Ortmann J; Prifti S; Bohlmann MK; Rehberger-Schneider S; Strowitzki T; Rabe T Gynecol Endocrinol; 2002 Apr; 16(2):113-20. PubMed ID: 12012621 [TBL] [Abstract][Full Text] [Related]
13. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115. Noguchi S; Kitamura Y; Uchida N; Yamaguchi K; Sato B; Matsumoto K Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825 [TBL] [Abstract][Full Text] [Related]
14. [Androgen receptors and effects of sex hormones on growth of a human ovarian carcinoma cell line]. Lu J; Zhang J; Zeng Y Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):360-2. PubMed ID: 7555372 [TBL] [Abstract][Full Text] [Related]
15. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells. Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477 [TBL] [Abstract][Full Text] [Related]
16. Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response. Soto AM; Lin TM; Sakabe K; Olea N; Damassa DA; Sonnenschein C Oncol Res; 1995; 7(10-11):545-58. PubMed ID: 8866667 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
18. Familial external genital ambiguity due to a transformation defect of androgen-receptor complexes that is expressed with 5 alpha-dihydrotestosterone and the synthetic androgen methyltrienolone. Kaufman M; Pinsky L; Bowin A; Au MW Am J Med Genet; 1984 Jul; 18(3):493-507. PubMed ID: 6332533 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a human, sex steroid-responsive transitional cell carcinoma maintained as a tumor line (R198) in athymic nude mice. Reid LM; Leav I; Kwan PW; Russell P; Merk FB Cancer Res; 1984 Oct; 44(10):4560-73. PubMed ID: 6467211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]